Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination

Abstract Introduction Rare myocarditis and pericarditis cases have occurred in coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccine recipients. Troponin levels, a potential marker of myocardial injury, were assessed in healthy participants before and after BNT162b2 vaccination. Methods V...

Full description

Bibliographic Details

Published in:	Infectious Diseases and Therapy
Main Authors:	Timothy E. Albertson, Caitlin Hansen, Smiti Bihari, Juleen Gayed, Xia Xu, J. Abraham Simón-Campos, Michael E. Dever, Jose F. Cardona, Essack Mitha, Jeffrey B. Baker, Georgina Keep, Islamiat Oladipupo, Federico J. Mensa, Ye Feng, Hua Ma, Kenneth Koury, Susan Mather, Claudia Ana Ianos, Annaliesa S. Anderson, Özlem Türeci, Uǧur Şahin, William C. Gruber, Alejandra Gurtman, Charu Sabharwal, Nicholas Kitchin, the C4591031, C4591007 Clinical Trial Groups
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2024-03-01
Subjects:	BNT162b2 Clinical trials COVID-19 Myocarditis Pericarditis Safety
Online Access:	https://doi.org/10.1007/s40121-024-00927-0